Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Subject

Year of publication

2 facets displayed. 0 facets selected.

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (3)

All (3) ((3 results))

  • Articles and reports: 82-003-X202600500002
    Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
    Release date: 2026-05-20

  • Articles and reports: 82-003-X202501000002
    Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.
    Release date: 2025-10-15

  • Articles and reports: 82-003-X202500600001
    Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.
    Release date: 2025-06-18
Articles and reports (3)

Articles and reports (3) ((3 results))

  • Articles and reports: 82-003-X202600500002
    Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
    Release date: 2026-05-20

  • Articles and reports: 82-003-X202501000002
    Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.
    Release date: 2025-10-15

  • Articles and reports: 82-003-X202500600001
    Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.
    Release date: 2025-06-18